Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.10 USD
Change Today 0.00 / 0.00%
Volume 200.0
As of 9:33 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

wound management technologie (WNDM) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/23/15 - $0.11
52 Week Low
11/21/14 - $0.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

wound management technologie (WNDM) Related Businessweek News

No Related Businessweek News Found

wound management technologie (WNDM) Details

Wound Management Technologies, Inc. develops, markets, and distributes collagen-based wound care products to physicians, clinics, and hospitals in the United States. The company offers CellerateRX, a medical device for use on acute and chronic wounds in gel and powder form. It also holds patents for a resorbable bone wax and delivery system for orthopedic bone void fillers. The company was formerly known as MB Software, Inc. and changed its name to Wound Management Technologies, Inc. in May 2008. Wound Management Technologies, Inc. was founded in 1982 and is based in Addison, Texas.

10 Employees
Last Reported Date: 05/1/15
Founded in 1982

wound management technologie (WNDM) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $150.0K
Total Annual Compensation: $150.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $94.4K
President of Wound Care Innovations LLC
Total Annual Compensation: $120.0K
Compensation as of Fiscal Year 2014.

wound management technologie (WNDM) Key Developments

Wound Management Technologies, Inc., Q1 2015 Earnings Call, Apr 22, 2015

Wound Management Technologies, Inc., Q1 2015 Earnings Call, Apr 22, 2015

Wound Management Technologies, Inc. Auditor Raises 'Going Concern' Doubt

Wound Management Technologies, Inc. filed its 10-K on Apr 09, 2015 for the period ending Dec 31, 2014. In this report its auditor, Malone & Bailey, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Wound Management Technologies, Inc. Reports Revenue Results for the Fourth Quarter and Year Ended December 31, 2014

Wound Management Technologies, Inc. reported revenue results for the fourth quarter and year ended December 31, 2014. For the quarter, the company's revenues increased 57% to $727,000 compared to the fourth quarter 2013. Revenues for the year ended December 31, 2014 of $2.632 million compared to revenues of $1.726 million for the year ended December 31, 2013, or a 52% increase in revenues.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WNDM:US $0.10 USD 0.00

WNDM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for WNDM.
View Industry Companies

Industry Analysis


Industry Average

Valuation WNDM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WOUND MANAGEMENT TECHNOLOGIE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at